Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2695

Actual shortage: 246 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2440 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-MOMETASONE 0.1% OINTMENT Actual shortage 2024-02-29 2024-06-07 220986
TEVA-SIMVASTATIN 5MG TABLET Actual shortage 2023-07-11 2024-06-07 198303
TEVA-SIMVASTATIN 5MG TABLET Actual shortage 2023-08-17 2024-06-07 202252
TEVA-SIMVASTATIN 20MG TABLET Actual shortage 2023-07-11 2024-06-07 198306
TEVA-OMEPRAZOLE 10MG TABLET (DELAYED-RELEASE) Actual shortage 2024-01-25 2024-06-07 217231
TEVA-CANDESARTAN 32MG TABLET Actual shortage 2024-03-28 2024-06-07 223853
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-03 2024-06-07 209148
TEVA-ENTACAPONE 200MG TABLET Actual shortage 2024-05-30 2024-06-07 229227
TEVA-TOBRAMYCIN 60MG SOLUTION Actual shortage 2024-05-09 2024-06-07 227495
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-18 2024-06-07 222572
TEVA-CINACALCET 90MG TABLET Actual shortage 2024-04-11 2024-06-07 224913
TEVA-CINACALCET 60MG TABLET Actual shortage 2024-04-11 2024-06-07 224910
TEVA-CINACALCET 30MG TABLET Actual shortage 2024-04-11 2024-06-07 224907
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-05-16 2024-06-07 228143
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Actual shortage 2024-03-07 2024-06-07 221537
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2024-03-07 2024-06-07 221534
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-05-03 2024-06-07 226945
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-01-11 2024-06-07 215751
TEVA-RIVAROXABAN 20MG TABLET Actual shortage 2024-05-09 2024-06-07 227456
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-06-07 223856

Showing 2661 to 2680 of 2695

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ATENOLOL 50MG TABLET Discontinued 2020-02-13 2020-02-13 106142
TEVA-ATENOLOL 100MG TABLET Discontinued 2020-02-13 2020-02-13 106145
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2020-02-13 2020-02-13 106148
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2020-02-13 2020-02-13 106158
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2020-02-13 2020-02-13 106161
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2020-02-13 2020-02-13 106167
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-PAROXETINE 10MG TABLET Discontinued 2020-02-21 2020-02-21 106898
TEVA-PAROXETINE 30MG TABLET Discontinued 2020-02-21 2020-02-21 106901
ACT RANITIDINE 150MG TABLET Discontinued 2020-05-14 2020-05-14 115079
ACT RANITIDINE 300MG TABLET Discontinued 2020-05-14 2020-05-14 115082
TEVA-ARIPIPRAZOLE 2MG TABLET Discontinued 2020-05-14 2020-05-14 115085
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2020-05-14 2020-05-14 115088
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
ACT DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115114

Showing 161 to 180 of 250